Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Jul 15,2015
House Approves NIH, FDA Funding Hikes
The U.S. House of Representatives today approved a bill intended to advance basic research and drug development, in part by giving the NIH $8.75 billion in additional funds over the next five federal fiscal years, and the FDA, $550 million. The 21st Century Cures Act (HR 6), creates a dedicated "Innovation Fund” from which theRead more
More
House Approves NIH, FDA Funding Hikes
Jul 14,2015
In Vitro Diagnostic Reagents Seeking Localization
Some leading in vitro diagnostic reagent companies in Guangdong Province are accelerating the implementation of product serialization, diagnostic accuracy, and reagent instrument integration. Some products have gone abroad and are actively exploring the international market June 11-12, under the guidance of the Medical Device Supervision Department of the State Food and Drug Administration, sponsored byRead more
More
Jul 09,2015
FDA offers guidance for running early-phase trials for gene, cell therapies
The FDA's Center for Biologics Evaluation and Research's Office of Cellular, Tissue, and Gene Therapies notes first and foremost that the development of cell and gene therapies differs drastically from the development of small molecule drugs, which means differences in trial design will be necessary. The heightened risk to subject safety is one of thoseRead more
More
Jul 09,2015
Animal research ban not possible says EC after rejecting petition
Animal research plays a crucial role in scientists’ understanding of diseases and in the development of effective medical treatments. The European Commission  made the comments today explaining that while it agrees drug toxicity tests using animals should eventually be phased out, at present it is impossible to do so as scientific challenges remain. "Where the toxicologicalRead more
More
Jul 07,2015
Mammary glands in a dish: Scientists recreate tissues for better models, spin out CRO planned
The scientists – from Ludwig Maximilian University (LMU) and the Helmholtz Center in Munich, Germany – used the gel to construct mammary gland like structures from breast epithelial cells extracted from healthy donors. Lead researcher Christina Scheel told us "we use a connective tissue component that is abundant in the human mammary gel to make.
More
Mammary glands in a dish: Scientists recreate tissues for better models, spin out CRO planned
Jun 26,2015
The European Council agrees to a general approach to the adoption of new regulatory proposals for therapeutic devices and in vitro diagnostic devices
After several weeks of discussion and thinking, the European Council finally agreed to adopt a general approach to the proposal of new regulations for medical devices and in vitro diagnostic devices (IVD). In the EU, the legislative process is that the European Commission (European Commission, EC) proposes a new bill, and then the European ParliamentRead more
More
The European Council agrees to a general approach to the adoption of new regulatory proposals for therapeutic devices and in vitro diagnostic devices
Mar 31,2015
Medicilon successfully held CFDA IND seminar in Seoul, South Korea
On March 18, Medicilon and Korea Pharmaceutical Manufacturers Association (KPMA) held a CFDA IND seminar in Seoul, South Korea. The theme of this seminar is "Experience Sharing and Exchange on CFDA's IND Application and Drug Development Collaboration”. About 130 medical experts and scientists from more than 50 companies participated in this seminar. Medicilon CEO Dr.Read more
More
Medicilon successfully held CFDA IND seminar in Seoul, South Korea
Jan 29,2015
Dr. Chen was appointed as Chairman of the Drug Metabolism Professional Committee
The Drug Metabolism Professional Committee of 4th Shanghai Pharmacological Societyand the 1st Symposium was held at Zhangjiang campus, Fudan University on January 29.  Dr. Chunlin Chen, Medicilon CEO, was appointed as Chairman of the Drug Metabolism Professional Committee of 4th Shanghai Pharmacological Society.  During the Syposium, Dr. Chen gave a keynote speech on the academicRead more
More
Jan 15,2015
Class 1.1 new chemical drug piperidone "AD16” has been accepted by CFDA IND
Alzheimer's disease, the English name is Alzheimer's disease (Alzheimer disease), abbreviated as AD is a neurodegenerative disease with insidious onset and progressive development. Clinically, it is characterized by general dementia such as memory impairment, aphasia, apraxia, agnosia, impairment of visual spatial skills, executive dysfunction, and personality and behavior changes. The etiology is still unknown. ThoseRead more
More
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->